about
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids.Lipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesAutophagy regulates sphingolipid levels in the liverThe pleiotropic roles of sphingolipid signaling in autophagyApolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death.Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.Effect of metformin on metabolic improvement and gut microbiotaPlasma sphingosine-1-phosphate is elevated in obesitySphingolipid metabolites in inflammatory disease.Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitusC16:0-ceramide signals insulin resistanceGlobal profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells.Sphingolipids are required for efficient triacylglycerol loss in conjugated linoleic Acid treated adipocytes.Δ10(E)-Sphingolipid Desaturase Involved in Fusaruside Mycosynthesis and Stress Adaptation in Fusarium graminearumRegulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling PathwayHigh-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes MellitusAnalysis of the Involvement of Different Ceramide Variants in the Response to Hydroxyurea Stress in Baker's Yeast.Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule.Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein ExpressionEthylene Modulates Sphingolipid Synthesis in Arabidopsis.TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1Why targeting HDL should work as a therapeutic tool, but has not.High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350.Ionic immune suppression within the tumour microenvironment limits T cell effector function.Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs.Ceramide signaling in mammalian epidermis.The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Quantitative metabolic profiling of lipid mediators.Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress.Phosphatidylserine Stimulates Ceramide 1-Phosphate (C1P) Intermembrane Transfer by C1P Transfer Proteins.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Reduced TORC1 signaling abolishes mitochondrial dysfunctions and shortened chronological lifespan of Isc1p-deficient cells.Systems Biology to Support Nanomaterial Grouping.Alterations of specific lipid groups in serum of obese humans: a review.
P2860
Q27000801-8790CD5B-5F2E-4AA0-AD28-F68DA592E561Q27939129-F869EEDA-D08A-454E-B028-E0902E41554CQ28073169-1AF1525C-E863-4FBE-A465-B6903639F142Q28115515-7CC25C3A-B03A-4C1D-BB24-4D7384E3CD26Q33720239-0A17E208-3D94-4045-B058-E40CB97A652BQ33945112-15B18108-0888-4A65-9EE4-77A39EDB04A3Q33986280-48892AAB-8E31-4551-9F13-36CE511083B9Q34138890-0053B697-C8E2-4432-827C-AB1B270B2FE1Q34261321-1C457F54-2E25-43FF-9009-910CC355F92AQ34988407-7D548E3D-B908-4B2B-9C5B-DE4F3F478F6DQ35061720-67B0CAD7-CCE4-4FA5-8052-649EA2E58B73Q35203823-03DFAEA6-FA90-443F-94FB-0802B44ABB93Q35362267-E34C4421-00A6-4C45-B4D6-2C531AC09EEBQ35551436-B10B4392-8633-44C4-87D0-06756DB02CD7Q35612813-4A9CF225-CFC1-4CF6-A14E-4811899A206DQ35632578-78251FC1-F47C-4E30-BAE4-2C037F526C9DQ35731006-A013E9F1-E06F-44DF-BED5-6DC7A725A296Q35755147-34B3BCDF-CFE1-40DE-9C26-3C1FB4F93A5DQ35852275-CDCBA165-5ECA-4037-93CE-E48988A89BBBQ35860169-90D0F136-C63C-4509-84B1-EA11AB79B807Q35897804-E7699950-296F-4CE6-ADD1-FD74A50346F3Q36036273-9BD5F240-37F4-4C45-9FD9-DF3C54E1F226Q36281733-2D832475-CDEC-4E62-9C01-C1A023605DEBQ36373921-CDB84370-F387-4EA7-B586-9F4D34B49B84Q36624553-2B2AD284-BA0D-49C5-931A-6B5B36FA1398Q37170464-DCC275FE-90E5-4458-B71D-F6C112E996BEQ37464707-7AC29506-2108-4DC8-B3C3-DF03EC9D9EE4Q37548587-FDFD688F-89D7-4BC0-9AB6-E883CAC275BAQ37549241-538F6FD2-4502-4A8E-B92B-1D6AB6FB7670Q37619251-FD091702-7B25-4BA6-87AC-05AA9A688E60Q37711953-40225736-D971-4E2F-AE2E-2857EE182B53Q38119472-383EE07A-E213-490E-9B5B-05A47A576D90Q38166800-BAA30CA0-5EFB-43DF-A380-A6370B1EDE2DQ38244084-B225E43A-6203-4579-B4A8-964AF112EFEDQ38277840-0A7E7256-81CC-4942-B4D6-66AA3F4A5A33Q38724553-F691A4D2-7BEE-44BF-8B71-B8692DA6437EQ38833111-48698661-24E8-48E2-B345-C43037E136D8Q38868037-3DE2EBC4-959C-4CC3-AD84-FFA05546F8CDQ38974885-08B2D293-85D0-476C-9581-8DB1F575BA6FQ39023727-5D08C298-4354-4888-8394-C502D3E410EB
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sphingolipid signaling in metabolic disorders
@ast
Sphingolipid signaling in metabolic disorders
@en
Sphingolipid signaling in metabolic disorders
@nl
type
label
Sphingolipid signaling in metabolic disorders
@ast
Sphingolipid signaling in metabolic disorders
@en
Sphingolipid signaling in metabolic disorders
@nl
prefLabel
Sphingolipid signaling in metabolic disorders
@ast
Sphingolipid signaling in metabolic disorders
@en
Sphingolipid signaling in metabolic disorders
@nl
P2860
P1433
P1476
Sphingolipid signaling in metabolic disorders
@en
P2093
Andrew J. Dannenberg
P2860
P304
P356
10.1016/J.CMET.2012.06.017
P407
P50
P577
2012-10-03T00:00:00Z